Albert Einstein College Of Medicine
Clinical trials sponsored by Albert Einstein College Of Medicine, explained in plain language.
-
Local health workers bridge gap for young adults with diabetes
Disease control CompletedThis study tested whether specially trained community health workers could help young adults from underrepresented minority groups start and keep using diabetes technology like continuous glucose monitors and insulin pumps. For 9 months, 119 participants were randomly assigned to…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Personalized cancer combo aims to control advanced lung tumors
Disease control CompletedThis Phase 2 trial tested a personalized treatment approach for patients with locally advanced non-small cell lung cancer (NSCLC). For patients whose tumors had high levels of a specific marker (PD-L1), researchers combined a 4-week personalized radiation course with an immunothe…
Phase: PHASE2 • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New Quit-Smoking strategy tested on heroes to prevent lung cancer
Prevention CompletedThis study tested whether a more proactive approach could help retired firefighters quit smoking and prevent lung cancer. Researchers compared a standard quit-smoking program against an enhanced program that automatically enrolled people and used personalized counseling based on …
Phase: PHASE4 • Sponsor: Albert Einstein College of Medicine • Aim: Prevention
Last updated Apr 01, 2026 21:25 UTC
-
Texting for health: can WhatsApp help stop HIV spread?
Prevention CompletedThis study tested whether a WhatsApp-based program could encourage more men who have sex with men in India to get tested for HIV and connect to preventive care like counseling or PrEP medication. Researchers compared the WhatsApp program to simpler approaches like just offering f…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Prevention
Last updated Mar 23, 2026 15:17 UTC
-
Immune protein infusion tested to stop agony of sickle cell crises
Symptom relief CompletedThis study tested whether a single dose of an immune protein therapy (IVIG) could safely shorten severe pain crises in people with sickle cell disease. About 300 children and adults were given either IVIG or a placebo saline solution during a hospital stay for a pain crisis. Rese…
Phase: PHASE1, PHASE2 • Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
At-Home brain zaps tested to slow Alzheimer's decline
Symptom relief CompletedThis study tested whether a gentle, at-home brain stimulation treatment could help people with mild to moderate Alzheimer's. One hundred participants used a device at home for 30 minutes, five days a week, for six months. The goal was to see if this non-invasive stimulation could…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
Could cannabis ease the agony of cancer treatment?
Symptom relief CompletedThis study looked at whether adding medical cannabis to standard supportive care helps head and neck cancer patients better tolerate the difficult side effects of combined chemotherapy and radiation. Researchers observed 30 patients who were already certified to use medical canna…
Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC
-
Virtual help for migraine sufferers: can telehealth reduce headaches?
Symptom relief CompletedThis small pilot study tested whether a 12-week telehealth program could help people manage migraines. Twenty participants with frequent migraines used a mobile app diary, online educational materials, and had video sessions with a provider. The main goal was to see if this appro…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Symptom relief
Last updated Mar 23, 2026 15:16 UTC
-
Marijuana's hidden risk for older women: study links cannabis to falls
Knowledge-focused CompletedThis study aimed to understand why older women who use cannabis have a higher risk of falling. Researchers compared how cannabis versus a placebo affected walking, balance, and thinking skills in 25 older women, some with HIV and some without. They tested participants under diffe…
Phase: PHASE2 • Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC